Contribution of the ROS-p53 feedback loop in thuja-induced apoptosis of mammary epithelial carcinoma cells

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1589-1598

  Saha, Shilpi ^a   Bhattacharjee, Pushpak ^a   Mukherjee, Shravanti ^a   Mazumdar, Minakshi ^a   Chakraborty, Samik ^a   Khurana, Anil ^b   Nayak, Debadatta ^b   Manchanda, Rajkumar ^b   Chakrabarty, Rathin ^b   Das, Tanya ^a   Sa, Gaurisankar ^a  

^a BOSE INSTITUTE   (India)

^b Central Council for Research in Homeopathy ^*  (India)

Author keywords

Apoptosis; Bax; Cancer; Homeopathy; P38MAPK; P53; ROS; Thuja

Indexed keywords

CASPASE; CEDAR LEAF OIL; MITOGEN ACTIVATED PROTEIN KINASE 14; PLACEBO; PROTEIN BAX; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER REGRESSION; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; THUJA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; FEEDBACK, PHYSIOLOGICAL; FEMALE; FLOW CYTOMETRY; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; THUJA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84908142759     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.2993     Document Type: Article

References (36)

1. Hanf V and Gonder U: Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk. Eur J Obstet Gynecol Reprod Biol 123: 139-149, 2005.
2. Cassileth BR and Vickers AJ: Complementary and alternative therapies. Urol Clin North Am 30: 369-376, 2003.
3. Flinn JE: Bromium in acute lymphatic leukemia. J Am Inst Homeopath 58: 213-214, 1965.
4. Gruchmann W: Arsenic: destroyer and healer; a contribution to the management of carcinoma. Hippokrates 27: 444-445, 1956 (In German).
5. Pathak S, Multani AS, Banerji P and Banerji P: Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol 23: 975-982, 2003.
6. Pathak S, Kumar Das J, Jyoti Biswas S and Khuda-Bukhsh AR: Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol Cell Biochem 285: 121-131, 2006.
7. Frenkel M, Mishra BM, Sen S, Yang P, Pawlus A, Vence L, Leblanc A, Cohen L, Banerji P and Banerji P: Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 36: 395-403, 2010.
8. Ojeswi BK, Khoobchandani M, Hazra DK and Srivastava MM: Protective effect of Thuja occidentalis against DMBA-induced breast cancer with reference to oxidative stress. Hum Exp Toxicol 29: 369-375, 2010.
9. Biswas R, Mandal SK, Dutta S, Bhattacharyya SS, Boujedaini N and Khuda-Bukhsh AR: Thujone-rich fraction of Thuja occidentalis demonstrates major anti-cancer potentials: evidences from in vitro studies on A375 cells. Evid Based Complement Alternat Med 2011: 568148, 2011.
10. Naser B, Bodinet C, Tegtmeier M and Lindequist U: Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. Evid Based Complement Alternat Med 2: 69-78, 2005.
11. Sunila ES and Kuttan G: Protective effect of Thuja occidentalis against radiation-induced toxicity in mice. Integr Cancer Ther 4: 322-328, 2005.
12. Sunila ES and Kuttan G: A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol Immunotoxicol 28: 269-280, 2006.
13. Dubey SK and Batra A: Hepatoprotective activity from ethanol fraction of Thuja occidentalis Linn. Asian J Res Chem 1: 32-35, 2008.
14. Dubey SK and Batra A: Antioxidant activity of Thuja occidentalis Linn. Asian J Pharm Clin Res 2: 73-76, 2009.
15. Efeyan A and Serrano M: p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6: 1006-1010, 2007.
16. Liu B, Chen Y and St Clair DK: ROS and p53: a versatile partnership. Free Radic Biol Med 44: 1529-1535, 2008.
17. Pervaiz S and Clement MV: Tumor intracellular redox status and drug resistance - serendipity or a causal relationship? Curr Pharm Des 10: 1969-1977, 2004.
18. Mandal D, Lahiry L, Bhattacharyya A, Chattopadhyay S, Siddiqi M, Sa G and Das T: Black tea protects thymocytes in tumor-bearing animals by differential regulation of intracellular ROS in tumor cells and thymocytes. J Environ Pathol Toxicol Oncol 24: 91-104, 2005.
19. Adhikary A, Mohanty S, Lahiry L, Hossain DM, Chakraborty S and Das T: Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk. FEBS Lett 584: 7-14, 2010.
20. Mazumdar M, Adhikary A, Chakraborty S, Mukherjee S, Manna A, Saha S, Mohanty S, Dutta A, Bhattacharjee P, Ray P, Chattopadhyay S, Banerjee S, Chakraborty J, Ray AK, Sa G and Das T: Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and p38MAPK/caspase-8 pathways. Apoptosis 18: 589-604, 2013.
21. Lahiry L, Saha B, Chakraborty J, Bhattacharyya S, Chattopadhyay S, Banerjee S, Choudhuri T, Mandal D, Bhattacharyya A, Sa G and Das T: Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis. Apoptosis 13: 771-781, 2008.
22. Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ Jr, Appella E and Anderson CW: Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 278: 37536-37544, 2003.
23. Freund A, Patil CK and Campisi J: p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 30: 1536-1548, 2011.
24. Murphy PJ, Galigniana MD, Morishima Y, Harrell JM, Kwok RP, Ljungman M and Pratt WB: Pifithrin-α inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation. J Biol Chem 279: 30195-30201, 2004.
25. Chang LC, Song LL, Park EJ, Luyengi L, Lee KJ, Farnsworth NR, Pezzuto JM and Kinghorn AD: Bioactive constituents of Thuja occidentalis. J Nat Prod 63: 1235-1238, 2000.
26. British Herbal Pharmacopoeia. Thuja, British Herbal Medicine Association, West Yorks, UK, 1983.
27. Thangapazham RL, Gaddipati JP, Rajeshkumar NV, Sharma A, Singh AK, Ives JA, Maheshwari RK and Jonas WB: Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integr Cancer Ther 5: 356-361, 2006.
28. MacLaughlin BW, Gutsmuths B, Pretner E, Jonas WB, Ives J, Kulawardane DV and Amri H: Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models. Integr Cancer Ther 5: 362-372, 2006.
29. Preethi K, Ellanghiyil S, Kuttan G and Kuttan R: Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: implications on mechanism of action. Integr Cancer Ther 11: 172-182, 2012.
30. Bishayee K, Paul A, Ghosh S, Sikdar S, Mukherjee A, Biswas R, Boujedaini N and Khuda-Bukhsh AR: Condurango-glycoside-A fraction of Gonolobus condurango induces DNA damage associated senescence and apoptosis via ROS-dependent p53 signalling pathway in HeLa cells. Mol Cell Biochem 82: 173-183, 2013.
31. Huschtscha L, Bartier W, Malmstrom A and Tattersall M: Cell-death by apoptosis following anticancer drug-treatment in vitro. Int J Oncol 6: 585-593, 1995.
32. Gu B and Zhu WG: Surf the post-translational modification network of p53 regulation. Int J Biol Sci 8: 672-684, 2012.
33. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E and Fornace AJ Jr: Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18: 6845-6854, 1999.
34. Sanchez-Prieto R, Rojas JM, Taya Y and Gutkind JS: A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res 60: 2464-2472, 2000.
35. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862, 2000.
36. Kim H, You S, Farris J, Foster LK and Foster DN: Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells. Oncogene 20: 3306-3310, 2001.